Beyond the epithelial tissue, a few cases of soft tissue tumors have been reported to carry BRD3/4::NUTM1 fusion genes, suggesting that the fusion gene can also collaborate with mesoderm-derived mesenchymal gene regulatory networks (GRNs) to drive NC (8). This evidence concerns the gene BRD3 and soft tissue neoplasm.